Recalled Food on Shelves Warns FDA Warns April 2007

 

Recalled Food on Shelves Warns FDA Warns April 2007

April 12, 2007 Recalled Food by the FDA

FDA is advising pet owners that recalled pet food may still be on the shelves in some retail establishments. FDA urges retailers across the country to be vigilant in removing all products associated with the pet food recall, which began on March 16, 2007.

To verify the effectiveness of the recall, FDA has conducted approximately 400 checks of retail stores across the country. Based on the checks, FDA believes most companies have removed the recalled product; however, some have not. FDA will continue to monitor retailers’ efforts to remove these items from the shelves.

“FDA’s priority is to make sure that cats and dogs have safe food to eat, said Stephen Sundlof, D.V.M., director of FDA’s Center for Veterinary Medicine.” Many of us are pet owners and animal lovers, and we want pet owners to feel assured that we are doing everything we can to make sure that all contaminated food is off the shelves.”

In related news, Menu Foods, Inc., a private label manufacturer based in Streetsville, Ontario, Canada, expanded its recall on Tuesday, April 10, to cat food not previously subject to the recall. The varieties of cat food in the United States and Canada now being recalled are included in the list at the bottom of this article. A complete list of Menu Foods’ recalled products, including the new items, can be reviewed at www.menufoods.com.

The company acted after receiving information from FDA, which had confirmed test results it received from a laboratory at University of California, Davis. The UC-Davis lab found that canned cat food which had not been included in Menu Food’s earlier recalls tested positive for melamine, a chemical used as a fertilizer and in the manufacture of cutlery and kitchenware.

The company informed FDA that it had shipped wheat gluten purchased from China and contaminated with melamine from its Emporia, Kansas plant to its plant in Streetsville. Some of the products produced with the contaminated wheat gluten also were shipped to the United States. FDA investigators and officials with the Canadian Food Inspection Agency were in the Ontario facility on April 11.

Since March 16, recalls of pet food products, including certain varieties of dog food, have been conducted by Menu Foods, Inc., Hill’s Pet Nutrition, P&G Pet Care, Nestle Purina PetCare Company, Del Monte Pet Products, and Sunshine Mills, Inc. Extensive information about the current pet food situation can be found at the FDA Web site, www.fda.gov.

There is now a single list of all recalled pet food located at http://www.fda.gov/ora/fed_state/recalls/Recall.xls which will be updated with any new recall information when announced.

LIST OF NEWLY RECALLED PRODUCTS:

Brand Look For This Date on The Bottom of Can or Back of Pouch Variety DescriptionCan/PouchSizeUPC
Americas Choice, Preferred PetJan/2/10Flaked Tuna 3ozCan3 oz54807-59114
Your PetDec/19/09Sliced Beef/Gravy 3ozCan3 oz72036-29026
Your PetJan/24/10
Your PetNov 06 09Sliced Variety Pack 3ozCan3 oz72036-40013
Pet PrideDec/19/09Sliced Beef/Gravy 3ozCan3 oz11110-86264
Pet PrideJan/24/10
Pet PrideNov 06 09Sliced Variety Pack 3ozCan3 oz11110-86003
Pet PrideDec 05 09
Pet PrideDec 06 09
Pet PrideJan 23 10
Pet PrideJan 24 10
Laura LynnJan/2/10Flaked Tuna 3ozCan3 oz86854-02407
Laura LynnDec/19/09Sliced Beef/Gravy 3ozCan3 oz86854-02406
NutriplanDec/19/09Sliced Beef/Gravy 3ozCan3 oz41130-06755
Price ChopperDec/19/09Sliced Beef/Gravy 3ozCan3 oz41735-12828
PublixJan/2/10Flaked Tuna 3ozCan3 oz41415-08327
PublixDec/19/09Sliced Beef/Gravy 3ozCan3 oz41415-08827
PublixJan/2/10
PublixJan/24/10
Stop & Shop CompanionJan/2/10Flaked Tuna 3ozCan3 oz88267-00286
Winn DixieDec/19/09Sliced Beef/Gravy 3ozCan3 oz21140-19419
Brand Look For This Date on The Bottom of Can or Back of Pouch Variety DescriptionCan/PouchSizeUPC
Nutro ProductsAll DatesChicken Cacciatore 3ozCan3 oz79105-35205
Nutro ProductsAll DatesOrleans Seafood Jambalaya 3ozCan3 oz79105-35206
Nutro ProductsAll DatesBeef Ragout 3ozCan3 oz79105-35207
Nutro ProductsAll DatesAlaskan Halibut/Rice 3ozCan3 oz79105-35221
Nutro ProductsAll DatesKitten Chicken/Lamb 3ozCan3 oz79105-35202
Nutro ProductsAll DatesCalifornia Chicken 3ozCan3 oz79105-30011
Nutro ProductsAll DatesLamb/Turkey Cutlets 3ozCan3 oz79105-30014
Nutro ProductsAll DatesSalmon/Whitefish 3ozCan3 oz79105-30013
Nutro ProductsAll DatesBeef/Egg 3ozCan3 oz79105-30015
Nutro ProductsAll DatesTurkey/Chicken Liver 3ozCan3 oz79105-30016
Nutro ProductsAll DatesSeafood/Tomato/Bisque 3ozCan3 oz79105-30017
Nutro ProductsAll DatesHunters Stew with Duck 3ozCan3 oz79105-30018
Nutro ProductsAll DatesHunters Stew with Venison 3ozCan3 oz79105-30019

Joint Update: FDA/USDA Update on Tainted Animal Feed

April 28, 2007

The U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) continue their investigation of imported rice protein concentrate which has been found to contain melamine and melamine-related compounds. Based on information currently available, FDA and USDA believe the likelihood of illness after eating pork from swine fed the contaminated product would be very low. The agencies are taking certain actions out of an abundance of caution. As announced on April 26, swine known to have been fed adulterated (contaminated) product will not be approved to enter the food supply. (Because the animal feed in question was adulterated, USDA cannot rule out the possibility that food produced from animals fed this product could also be adulterated. USDA cannot approve potentially adulterated meat.) This update provides additional information regarding the ongoing investigation.

As reported on April 22 by FDA, the Agency determined that rice protein concentrate imported from China was contaminated with melamine and melamine-related compounds. The product was imported by Wilbur-Ellis, an importer and distributor of agricultural products. Although the company began importing product from China in August 2006, the company did not become aware of the contamination until April 2007. As part of the ongoing investigation, FDA has determined the rice protein was used in the production of pet food and a portion of the pet food was used to produce animal feed. The ongoing investigation is tracing products distributed since August 2006 by Wilbur-Ellis throughout the distribution chain.

At this time, we have no evidence of harm to humans associated with the processed pork product, and therefore no recall of meat products processed from these animals is being issued. Testing and the joint investigation continue. If any evidence surfaces to indicate there is harm to humans, the appropriate action will be taken.

The assessment that, if there were to be harm to human health, it would be very low, is based on a number of factors, including the dilution of the contaminating melamine and melamine-related compounds from the original rice protein concentrate as it moves through the food system. First it is a partial ingredient in the pet food; second, it is only part of the total feed given to the hogs; third, it is not known to accumulate in the hogs and the hogs excrete melamine in their urine; fourth, even if present in pork, pork is only a small part of the average American diet. Neither FDA nor USDA has uncovered any evidence of harm to the swine from the contaminated feed. In addition to the dilutional factor and the lack of evidence of illnesses in the swine fed the waste pet food, we are not aware of any human illness that has occurred from exposure to melamine or its by-products. While the Centers for Disease Control and Prevention systems would have limited ability to detect subtle problems due to melamine and melamine-related compounds, no problems have been detected to date. To further evaluate any potential harm to humans, the FDA is developing and implementing further tests and risk assessments based on the toxicity of the compounds and how much of the compounds consumers could be expected to actually consume.

The ongoing investigation and product reconciliation and testing have led to certain farms. We expect the investigation will continue to find more places where product may have been distributed. As of April 26, sites in the following states are believed to have received and used contaminated product: California, Kansas, New York, North Carolina, South Carolina and Utah. As we confirm additional sites that have received and used contaminated product, we will provide additional updates.

USDA and FDA continue to conduct a full, comprehensive examination to protect the nation's food supply and will provide updates as new information is confirmed.

First Drug to Treat Cancer in Dogs Approved

The U.S. Food and Drug Administration announced the approval of Palladia (toceranib phosphate), the first drug developed specifically for the treatment of cancer in dogs.

Palladia is approved to treat canine cutaneous (skin-based) mast cell tumors, a type of cancer responsible for about 1 out of 5 cases of canine skin tumors. The drug is approved to treat the tumors with or without regional lymph node involvement.

All cancer drugs now used in veterinary medicine originally were developed for use in humans and are not approved for use in animals. Cancer treatments used in animals are used in an "extra-label" manner as allowed by the Animal Medicinal Drug Use Clarification Act of 1994.

"This cancer drug approval for dogs is an important step forward for veterinary medicine," said Bernadette Dunham, D.V.M., Ph.D., director of FDA's Center for Veterinary Medicine. "Prior to this approval, veterinarians had to rely on human oncology drugs, without knowledge of how safe or effective they would be for dogs. Today's approval offers dog owners, in consultation with their veterinarian, an option for treatment of their dog's cancer."

While canine mast cell tumors often appear small and insignificant, they can be a very serious form of cancer in dogs. Some mast cell tumors are easily removed without the development of any further problems, while others can lead to life threatening disease.
Palladia is a tyrosine kinase inhibitor and works in two ways: by killing tumor cells and by cutting off the blood supply to the tumor. In a clinical trial, Palladia showed a statistically significant difference in tumor shrinkage when compared with an inactive substance (placebo).

The most common side effects associated with Palladia are diarrhea, decrease or loss of appetite, lameness, weight loss, and blood in the stool.

Palladia is manufactured by Pfizer Animal Health Inc., New York City.